Tag: Lenacapavir
-
Aden Duale Launches Long-Acting Injectable HIV Prevention Drug in Nationwide Rollout
Cabinet Secretary for Health Hon. Aden Duale has officially launched the long-acting injectable HIV pre-exposure prophylaxis (PrEP) known as Lenacapavir, marking the first phase of its nationwide rollout and signaling Kenya’s renewed push to end the HIV epidemic through innovative, people-centred prevention strategies. The introduction of Lenacapavir represents a significant milestone in the country’s HIV…
-
Kenya Approves Lenacapavir Rollout as Long-Acting HIV Prevention Breakthrough
The Kenyan government has given the green light for the introduction of Lenacapavir, a breakthrough long-acting drug designed to prevent HIV infection, marking a major milestone in the country’s HIV response. The Ministry of Health, acting through the Pharmacy and Poisons Board (PPB), on January 10 approved the registration of Lenacapavir 300 mg oral tablets…